AAAbdulmohsen I. Algefare

Abdulmohsen I. Algefare

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Abdulmohsen I. Algefare has a total of 28 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Centaurea virgata Lam. Instigates EtOH‐Induced Gastric Toxicity/Ulcer In Vivo: Role of SOD/MDA, Bax/HSP 70, and TNF‐α/IL‐10

    by Khalid M. Alqaisi, Essa Qarani Rashid, Abdulrahman Ismael, Hawar Jawdat Jaffar, Ahmed A. J. Jabbar, Gharieb S. El-Sayyad, Hanan Ibrahim Alsharif, Abdulmohsen I. Algefare, Manal A. Alfwuaires, Marwa Yousry A. Mohamed, et al.

    Centaurea virgata is broadly used as a traditional food and medicine across the globe for numerous health purposes. Although the species is reported to have antioxidant and anti‐inflammatory activities, literature data on its gastroprotective effects are scarce. Due to numerous shortcomings of conventional anti‐ulcer drugs, natural products gained renewed interest as a safer alternative. This study aimed to investigate the acute toxicity and gastroprotective effects of the aerial part extracts of Centaurea virgata (APCV) on ethanol‐induced gastric ulcers in Sprague–Dawley rats. Rats were divided into 5 groups: normal control, ulcer control (saline + EtOH), reference (lansoprazole + EtOH), APCV 100 mg/kg + EtOH, and APCV 200 mg/kg + EtOH. APCV 100 or 200 mg/kg, administered orally 1 h before the ethanol‐induced ulcer procedure delivery, increased the protective index % (26.82% and 31.40%, respectively). The histopathological results (using H&E and PAS) indicated preserved gastric defense barriers (restored mucus secretion and gastric pH) and tissue architecture as a result of APCV pretreatment. APCV intervention (100 and 200 mg/kg) increased superoxide dismutase by 24.33% and 62.14%; catalase by 59.07% and 90.37%; and upregulated IL‐10 by 24.40% and 79.52%, while significantly ( p < 0.01) lowering MDA by 25.97% and 38.77%, as well as significantly ( p < 0.001) downregulated IL‐6 by 14.67% and 33.08% and TNF‐α by 37.82% and 47.59%, respectively, compared to ulcer controls. It could also be noted that inhibited apoptosis (inhibited pro‐apoptotic Bax and increased HSP 70 appearances in gastric tissues) occurred in gastric tissues pretreated with APCV. Taken together, APCV exhibited a gastroprotective potential against gastric ulcers, which is attributed to its attenuation effects on oxidative stress, inflammatory, and apoptotic pathways.


  • Open Access

    Hepatoprotective effect of taxifolin on cyclophosphamide-induced oxidative stress, inflammation, and apoptosis in mice: Involvement of Nrf2/HO-1 signaling

    by Osama Y. Althunibat, Mohammad H. Abukhalil, Muthana M. Jghef, Manal A. Alfwuaires, Abdulmohsen I. Algefare, Bader Alsuwayt, Reem Alazragi, Mohammed A. S. Abourehab, Afaf F. Almuqati, Shaik Karimulla, et al.

    Taxifolin (TA) is a natural flavonoid found in many foods and medicinal plants with well-documented antioxidant and anti-inflammatory properties. Cyclophosphamide (CP) is an effective antineoplastic and immunosuppressive agent; however, it is associated with numerous adverse events, including hepatotoxicity. Herein, we aimed to investigate the potential protective effects of TA using a mouse model of CP-induced hepatotoxicity. Mice were co-treated with TA (25 and 50 mg/kg, orally) and CP (30 mg/kg, i.p.) for 10 consecutive days and sacrificed 24 hours later. CP induced increased transaminases (ALT and AST), alkaline phosphatase (ALP), and lactate dehydrogenase (LDH) paralleled with pronounced histopathological alterations in the liver. Moreover, hepatic tissues of CP-injected mice showed increased malondialdehyde (MDA), protein carbonyl, and nitric oxide (NO) levels, accompanied by decreased antioxidant defenses (glutathione [GSH], superoxide dismutase [SOD], and catalase [CAT]). Livers of CP-injected mice also showed increased inflammatory response (nuclear transcription factor kappa-B [NF-κB] p65 activation, increased levels of proinflammatory cytokines tumor necrosis factor alpha [TNF-α], interleukin 1 beta [IL-1β], and IL-6) and apoptosis (decreased Bcl-2 and increased Bax and caspase-3 expression levels). Remarkably, TA ameliorated markers of liver injury and histological damage in CP-injected mice. TA treatment also attenuated numerous markers of oxidative stress, inflammation, and apoptosis in the liver of CP-injected mice. This was accompanied by increased nuclear factor erythroid 2-related factor 2 (Nrf2)/heme oxygenase 1 (HO-1) expression in the liver tissues of CP-injected mice. Taken together, this study indicates that TA may represent a promising new avenue to prevent/treat CP-induced hepatotoxicity and perhaps other liver diseases associated with oxidative stress and inflammation.


  • Open Access

    Immunomodulatory assessment of Portulaca oleracea L. extract in a mouse model of colitis

    by Manal A. Alfwuaires, Abdulmohsen I. Algefare, Eman Afkar, Sherine Abdel Salam, Heba Ibrahim Abd El-Moaty, Gehan M. Badr